You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 105 No. 5, May 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Topical Therapy of Psoriasis With Mechlorethamine

Herschel S. Zackheim, MD; James E. Arnold, MD; Eugene M. Farber, MD; Alvin J. Cox, Jr., MD

Arch Dermatol. 1972;105(5):702-706.


Abstract

Aqueous solutions of mechlorethamine (Mustargen) hydrochloride (0.055 to 0.00625%) have been used in courses of seven to ten days on lesions of psoriasis in 42 patients. A significant involutionary effect was obtained with the 0.0125% to 0.05% concentrations, particularly on the trunk. The rate of contact sensitization ranged from 50% to more than 80%, and was highest with the 0.05% concentration. Occasional Koebner reactions and paradoxical results were noted. The high rate of sensitization precludes the use of this agent in the practical management of psoriasis.



Author Affiliations

Stanford, Calif

From the Department of Dermatology, Stanford (Calif) University School of Medicine. Dr. Zackheim is now with the University of California School of Medicine, San Francisco.


Footnotes

Accepted for publication Oct 1, 1971.

Reprint requests to the Department of Dermatology, University of California School of Medicine, San Francisco 94122 (Dr. Zackheim).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Treatment of Mycosis Fungoides With Ointment-Based Mechlorethamine
Price et al.
Arch Dermatol 1982;118:234-237.
ABSTRACT  

Topical Mechlorethamine: Cutaneous Changes in Patients With Mycosis Fungoides After Its Administration
Price
Arch Dermatol 1977;113:1387-1389.
ABSTRACT  

An Appraisal of Current Systemic Chemotherapy for Psoriasis
Farber et al.
Arch Dermatol 1976;112:1679-1688.
ABSTRACT  

Intravenous Desensitization to Mechlorethamine in Patients With Psoriasis
Pariser et al.
Arch Dermatol 1976;112:1113-1114.
ABSTRACT  

Treatment of Mycosis Fungoides With Topical Nitrosourea Compounds: Further Studies
Zackheim and Epstein
Arch Dermatol 1975;111:1564-1570.
ABSTRACT  

Mechlorethamine in Psoriasis: Further Attempts to Induce Immunological Tolerance
Breza et al.
Arch Dermatol 1975;111:1438-1439.
ABSTRACT  

Topical Colchicine Therapy for Recalcitrant Psoriasis
Kaidbey et al.
Arch Dermatol 1975;111:33-36.
ABSTRACT  

Effects of Methotrexate and Hydroxyurea on Psoriatic Epidermis: Preferential Cytotoxic Effects on Psoriatic Epidermis
Smith and Gelfant
Arch Dermatol 1974;110:70-72.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.